Literature DB >> 9466522

Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men.

J M Palefsky1, E A Holly, M L Ralston, N Jay.   

Abstract

One of the groups at highest risk of anal cancer is homosexual and bisexual men. Like cervical cancer, anal cancer is associated with human papillomavirus (HPV) infection. Anal HPV infection was characterized in a study of 346 human immunodeficiency virus (HIV)-positive and 262 HIV-negative homosexual and bisexual men. Anal HPV DNA was detected in 93% of HIV-positive and 61% of HIV-negative men by polymerase chain reaction. The spectrum of HPV types was similar in HIV-positive and HIV-negative men, with HPV-16 the most common type. Infection with multiple HPV types was found in 73% of HIV-positive and 23% of HIV-negative men. Among HIV-positive men who were positive by hybrid capture for group B HPV types (16/18/31/33/35/39/45/51/52/56/58) or group A types (6/11/42/43/44), lower CD4 cell levels were associated with higher levels of group B DNA (P = .004) but not group A DNA. These data suggest increased replication of the more oncogenic HPV types with more advanced immunosuppression.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9466522     DOI: 10.1086/514194

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  132 in total

Review 1.  Cell-mediated immune response to human papillomavirus infection.

Authors:  M Scott; M Nakagawa; A B Moscicki
Journal:  Clin Diagn Lab Immunol       Date:  2001-03

2.  Infection with Human Papillomavirus: Update on Epidemiology, Diagnosis, and Treatment.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-02       Impact factor: 3.725

3.  The Interaction Between HIV and the Classic Sexually Transmitted Diseases.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-02       Impact factor: 3.725

4.  Does framing human papillomavirus vaccine as preventing cancer in men increase vaccine acceptability?

Authors:  Annie-Laurie McRee; Paul L Reiter; Kim Chantala; Noel T Brewer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-07-20       Impact factor: 4.254

Review 5.  [HPV-induced anal lesions].

Authors:  U Wieland; A Kreuter
Journal:  Hautarzt       Date:  2015-06       Impact factor: 0.751

6.  Sociodemographic Predictors of Anal Cancer Screening and Follow-up in Human Immunodeficiency Virus-Infected Individuals.

Authors:  Jessica S Wells; Marcia M Holstad; Deborah Watkins Bruner
Journal:  Cancer Nurs       Date:  2018 Sep/Oct       Impact factor: 2.592

7.  Safety and immunogenicity of the quadrivalent human papillomavirus (qHPV) vaccine in HIV-positive Spanish men who have sex with men (MSM).

Authors:  Carmen Hidalgo-Tenorio; Jessica Ramírez-Taboada; Concepción Gil-Anguita; Javier Esquivias; Mohamed Omar-Mohamed-Balgahata; Antonio SamPedro; Miguel Lopez-Ruz; Juan Pasquau
Journal:  AIDS Res Ther       Date:  2017-07-18       Impact factor: 2.250

8.  Safety and efficacy of topical cidofovir to treat high-grade perianal and vulvar intraepithelial neoplasia in HIV-positive men and women.

Authors:  Elizabeth A Stier; Stephen E Goldstone; Mark H Einstein; Naomi Jay; John M Berry; Timothy Wilkin; Jeannette Y Lee; Teresa M Darragh; Maria Da Costa; Lori Panther; David Aboulafia; Joel M Palefsky
Journal:  AIDS       Date:  2013-02-20       Impact factor: 4.177

Review 9.  [Anal dysplasia and anal cancer].

Authors:  Ulrike Wieland; Frank Oellig; Alexander Kreuter
Journal:  Hautarzt       Date:  2020-04       Impact factor: 0.751

10.  Squamous dysplasia of the rectum in a patient with ulcerative colitis treated with 6-mercaptopurine.

Authors:  Rachel Greenberg; Bruce Greenwald; J Scott Roth; Olga Ioffe; Raymond Cross
Journal:  Dig Dis Sci       Date:  2007-08-24       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.